The safety and efficacy of human umbilical cord mesenchymal stem cell for acute respiratory distress syndrome: an open-label and multicenter phase 1 clinical trial.
Saved in:
| Title: | The safety and efficacy of human umbilical cord mesenchymal stem cell for acute respiratory distress syndrome: an open-label and multicenter phase 1 clinical trial. |
|---|---|
| Authors: | Ge Q; Department of Intensive Care Medicine, Peking University Third Hospital, Beijing, China., Zheng L; Stem Cell Biology and Regenerative Medicine Institution, Yi-Chuang Institute of Bio-Industry, Beijing, China., Zhao M; Department of Intensive Care Medicine, Peking University Third Hospital, Beijing, China., Li C; Department of Intensive Care Medicine, Peking University Third Hospital, Beijing, China., Zhao Z; Department of Intensive Care Medicine, Peking University Third Hospital, Beijing, China., Wang Z; Department of Intensive Care Medicine, Peking University Third Hospital, Beijing, China., Zhang Q; Department of Intensive Care Medicine, Peking University Third Hospital, Beijing, China., Shi M; Department of Intensive Care Medicine, Peking University Third Hospital, Beijing, China., Li Y; Department of Intensive Care Medicine, Peking University Third Hospital, Beijing, China., Zhang J; Department of Intensive Care Medicine, Peking University Third Hospital, Beijing, China., Qiao Y; Department of Pulmonary and Critical Care Medicine, Peking University Third Hospital, Beijing, China., Wei S; Department of Intensive Care Medicine, Peking University Third Hospital, Beijing, China., Shen N; Department of Pulmonary and Critical Care Medicine, Peking University Third Hospital, Beijing, China., Long H; Stem Cell Biology and Regenerative Medicine Institution, Yi-Chuang Institute of Bio-Industry, Beijing, China., Liu Y; Stem Cell Biology and Regenerative Medicine Institution, Yi-Chuang Institute of Bio-Industry, Beijing, China., Qiao J; State Key Laboratory of Female Fertility Promotion, Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Jun 10; Vol. 17, pp. 1848989. Date of Electronic Publication: 2026 Jun 10 (Print Publication: 2026). |
| Publication Type: | Journal Article; Multicenter Study; Clinical Trial, Phase I |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1848989 |
